When administering paraquat at low doses, it has been shown to cause an upregulation of α-synuclein in wild-type mice [92] and to increase markers of α-synuclein aggregation in the ENS in a transgenic model of synucleinopathy [93]. The gene discussed is SNCA; the disease is synucleinopathy.